Human TNFSF14(Tumor Necrosis Factor Ligand Superfamily, Member 14)CLIA Kit

The HUMAN TNFSF14 CLIA KIT is a highly sensitive and specific assay designed to detect and quantify the levels of Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14) in human serum, plasma, and cell culture supernatants. TNFSF14 is a cytokine that plays a crucial role in the regulation of immune responses and inflammation. It is involved in the activation of T cells, B cells, and natural killer cells, and is also known to induce apoptosis in certain types of cancer cells.

The kit utilizes a sandwich enzyme-linked immunosorbent assay (ELISA) format, which involves the use of two specific antibodies that bind to different epitopes of TNFSF14. The first antibody is coated onto the wells of a microplate, and the sample is added to the wells, allowing TNFSF14 to bind to the immobilized antibody. The second antibody, conjugated to a detection enzyme, is then added, which binds to the TNFSF14 captured by the first antibody. The amount of TNFSF14 present in the sample is then quantified by measuring the enzymatic activity of the detection enzyme.

The HUMAN TNFSF14 CLIA KIT is a reliable and accurate tool for the detection and quantification of TNFSF14 in human samples. It has a wide dynamic range, with a lower limit of detection of 0.1 pg/mL, and can detect TNFSF14 levels as low as 0.5 pg/mL. The kit is easy to use, with a simple protocol that can be completed in less than 4 hours. It is suitable for use in research studies investigating the role of TNFSF14 in various diseases, including cancer, autoimmune disorders, and infectious diseases.